GlaxoSmithKline's IFRS net income for 6 months 2021 was £2.798 billion, down 32.1% from £4.119 billion in the previous year. Turnover declined 7.2% to £15.51 billion from £16.714 billion a year earlier.
GlaxoSmithKline's IFRS net income for 6 months 2021 was £2.798 billion, down 32.1% from £4.119 billion in the previous year. Turnover declined 7.2% to £15.51 billion from £16.714 billion a year earlier. 
gsk.com
English (US) 